Next Article in Journal
Beneficial Probiotics with New Cancer Therapies for Improved Treatment of Hepatocellular Carcinoma
Next Article in Special Issue
Rabies Vaccination and Public Health Insights in the Extended Arabian Gulf and Saudi Arabia: A Systematic Scoping Review
Previous Article in Journal
Is Oral Function Associated with the Development of Sarcopenic Obesity and Sarcopenia in Older Adults? A Prospective Cohort Study
Previous Article in Special Issue
Quality Management Outweighs Pandemic: Retrospective Analysis Shows Improved Quality of Care for Staphylococcus aureus Bacteremia Despite SARS-CoV-2
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Onychomycosis Endonyx: A Systematic Review

by
Ernesto De-La-Rosa-Garibay
1,2,3,†,
Roberto Arenas
1,†,
Martha Y. Herrera-Castro
1,
Alicia Valdez-Gaona
1,3,
Gabriela Moreno-Coutiño
1,
Paola Berenice Zarate-Segura
4,
Fernando Bastida-González
5,
Erick Martínez-Herrera
4,6,7,* and
Rodolfo Pinto-Almazán
4,6,*
1
Mycology Section, Hospital General Dr. Manuel Gea González, Mexico City 14080, Mexico
2
Internal Medicine, Hospital General de Zona No. 27 “Dr. Alfredo Badallo García”, Intituto Mexicano del Seguro Social, Lerdo 311, Tlatelolco, Cuauhtémoc, Mexico City 06900, Mexico
3
Facultad de Medicina, Universidad Nacional Autónoma de México, Escolar 411A, Copilco Universidad, Coyoacán, Mexico City 04360, Mexico
4
Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Mexico City 11340, Mexico
5
Laboratorio de Biología Molecular, Laboratorio Estatal de Salud Pública del Estado de México, Mexico City 50130, Mexico
6
Fundación Vithas, Grupo Hospitalario Vithas, 28043 Madrid, Spain
7
Efficiency, Quality, and Costs in Health Services Research Group (EFISALUD), Galicia Sur Health Research Institute (IISGS), Servizo Galego de Saúde-Universidade de Vigo (UVIGO), 36213 Vigo, Spain
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Diseases 2025, 13(4), 110; https://doi.org/10.3390/diseases13040110
Submission received: 8 March 2025 / Revised: 2 April 2025 / Accepted: 3 April 2025 / Published: 7 April 2025
(This article belongs to the Special Issue Infectious Disease Epidemiology 2024)

Abstract

:
Background/Objectives: Endonyx onychomycosis is a chronic infection of the nail plate that presents as milky white discoloration, without hyperkeratosis or onycholysis, and was originally described as being caused by T. soudanense and T. violaceum. Methods: In the present review, the definitions used in the different articles and the clinical characteristics of patients diagnosed with this onychomycosis variant were analyzed through a systematic review of the reported cases in the literature using the terms “endonyx” AND “onychomycosis” in PUBMED, SciELO, SCOPUS, Web of Science, and Google Academics databases. Results: We found 28 articles with a total of 175 patients diagnosed with endonyx onychomycosis, mainly reported in Asia and Africa. Nine papers presented detailed descriptions. From these, a total of 15 immunocompetent patients were registered, and the etiological agents reported were Trichophyton soudanense, T. rubrum, T. violaceum, T. tonsurans, and Fusarium spp. After analyzing the definitions employed in the remaining articles, only 47.3% cited or described a concept consistent with the original description. The other 47.3% of the studies lacked a traceable criterion for the diagnosis of these cases. Moreover, most studies analyzed their data at a global level, describing little information to provide specific insights into the endonyx variant. Conclusions: Emphasis on clinical description and histopathological analysis is essential to confirm the role of less commonly reported fungi, and more accurate diagnostic and treatment protocols for this condition are mandatory.

1. Introduction

Onychomycosis, the most common nail disease worldwide, is a chronic infection of the nail plate with a wide range of clinical features that can affect finger and/or toenails. It is caused by fungi, most frequently dermatophytes, but it can also be due to yeasts (mainly Candida spp.) and Non-Dermatophyte Molds (Scopulariopsis brevicaulis, Fusarium spp., and Aspergillus spp.) [1,2,3].
Clinical classification is an important tool in the medical approach, as the treatment is based on clinical features, and sometimes on the etiological agent involved [2].
Hay et al., in 2011, classified onychomycosis as: distal and lateral subungual onychomycosis (DLSO), superficial white onychomycosis (SWO), proximal subungual white onychomycosis (PSWO), endonyx (EO), mixed pattern onychomycosis (MPO), total dystrophic onychomycosis (TDO), and secondary onychomycosis [4].
The endonyx type was formerly described by Tosti et al. and included in the new classification by Baran et al. in the late nineties [5,6]. The original report was based on the description of three patients with diffuse white milky discoloration of the nail plate, no evidence of hyperkeratosis or onycholysis, and histopathological findings did not show inflammatory changes in the nail bed. Initially, the cases were associated with Trichophyton soudanense and with other previously reported cases of nail infection by Trichophyton violaceum, with similar histopathological features [7].
It is mandatory to point out the differences between the different forms of onychomycosis. In endonyx, there is an absence of subungual hyperkeratosis; whereas this characteristic is always present in distal and lateral subungual onychomycosis, with the presence of tinea pedis in most cases. Whereas in both forms of leukonychia (WSO, PSWO), white nails are characteristic, and the second form is more frequent in immunocompromised patients [6].
After 25 years of the initial report, we consider that a systematic review of the topic is essential to integrate recent findings and update existing knowledge. Below, we will review the current evidence on endonyx onychomycosis focusing on clinical manifestations, geographic distribution, and the research methodologies used to study this pathology.

2. Materials and Methods

2.1. Identification

The review was conducted based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [8]. An advanced search was performed on November 2024, in five databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PUBMED), Scientific Electronic Library Online (SciELO), SCOPUS, Web of Science, and Google Scholar, using the terms “endonyx” AND “onychomycosis”, looking for patients diagnosed with endonyx onychomycosis, confirmed by mycological studies, in case reports, case series, clinical trials, and observational studies, from 1 October 1998 to 31 November 2024, published in English and Spanish, with no filters or limits used. We found a total of 891 articles.

2.2. Screening and Selection Standards

In order to ensure data accuracy, we eliminated the duplicate articles between the different databases, which numbered 141. We also excluded 25 papers where we could not find the abstract or full text. Exclusion criteria included book chapters, reviews and systematic reviews, or clinical diagnoses not confirmed by a mycological study. Titles, abstracts, and full texts of each potential article were evaluated by three independent reviewers (De-La-Rosa-Garibay, Herrera-Castro, and Valdez-Gaona), and details regarding study inclusion were resolved by a consensus of three reviewers (Arenas, Martínez-Herrera, and Pinto-Almazán).

2.3. Data Acquisition

At the end of this process, 34 articles were assessed for eligibility. Four papers could not be retrieved, and three articles were excluded, one because it only presented a clinical picture without further data [9], and the other two [10,11] had the same population as other articles [12,13]. Additionally, 2 references were identified in citation searching; one was not retrieved because we could not locate the publication [14]. Finally, 28 articles were included (Figure 1). Data were collected on the following characteristics: total number of diagnosed cases, geographical location, demographic characteristics (sex and age), anatomical location (fingers or toes and number of affected nails), clinical findings, direct examination results (when available), histopathological findings (in cases with histopathological studies), identified etiological agents (when it could be determined), patients’ immune status, and the presence of associated tinea infections. Data extraction was performed by three reviewers (De-La-Rosa-Garibay, Herrera-Castro, and Valdez-Gaona) using the software Microsoft Excel, Microsoft Office 2021.

2.4. Quality Assessment

To assess the risk of measurement bias in the diagnosis of endonyx onychomycosis, we systematically analyzed the definitions utilized in the articles included in the review. Each definition was then compared to the characteristics originally described by Tosti et al. [5]. When a detailed description of the case was available, these were documented and compared in Table 1. In contrast, when the percentage of the reported cases was the only data obtainable, the total number of cases was calculated (based on the total number of patients included in the study), and then reported in Table 2. Additionally, the precise definition was identified either within the text or cited bibliography where they explicitly mention the endonyx concept. This methodology allows us to determine the consistency and accuracy of the terms employed. To assess the quality of this study, the PRISMA 2020 checklist was used [8]. No attempts were made to contact the authors of the studies that presented limited information on the cases. This decision was due to time and resource limitations for the review, as well as the low likelihood of obtaining a response within the study’s timeframe.

3. Results

Twenty-eight articles fulfilled the inclusion criteria: clinical cases (n = 5) [15,16,17,18,19], case series (n = 3) [5,7,20], observational studies (n = 14) [12,13,23,24,26,27,28,29,30,31,32,35,38], and clinical trials (n = 6) [25,30,33,34,36,37]. Regarding its global distribution, 175 patients were found with a diagnosis of endonyx onychomycosis in Asia (n = 71), Africa (n = 60), America (n = 15), and Europe (n = 14) (Table 2).
In Asia, 71 cases have been reported to date, with India having the highest number (n = 56), followed by Iran (n = 9) and Taiwan (n = 3). Likewise, in Africa, a total number of 60 cases were found distributed in four countries: Botswana (n = 47), Cameroon (n = 9), Egypt (n = 2), and Somalia (n = 2). In America, 15 cases have been diagnosed, and the most affected countries have been the United States (n = 10), Brazil (n = 4), and Argentina (n = 1). Europe is the continent with the lowest number of diagnosed cases, with a total of 14, present mainly in Serbia (n = 6) and France/Italy (n = 3). In addition, 15 cases were registered in France, together with its overseas departments and territories (French Caribbean, French Guyana, and Reunion Island), located in America, Africa, and Europe. As they could not be traced to a single continent, they are presented independently (Table 2 and Figure 2).
Five clinical cases, three case series, and one non-randomized control trial [21] included a detailed description of the diagnosed patients. From them, a total of fifteen immunocompetent patients were registered—nine men and six women—with an age range from 7 to 69 years old. The characteristics described by Tosti et al. [5] in 1999 were used to guide us when determining the similarities and differences with the other published reports. The cases were divided for the analysis according to the etiological agent: six cases of Trichophyton soudanense, six of T. rubrum, one of T. violaceum, one of T. tonsurans, and one of Fusarium spp. The summary of the epidemiological, clinical, mycological, and histopathological characteristics from these cases is presented in Table 1.
Among the remaining studies, one randomized controlled trial [33] provided an explicit description; eight observational studies cited bibliography where endonyx onychomycosis was presented as milky white discoloration, without hyperkeratosis or onycholysis [39,40], accounting for 47.3% of the included articles. In contrast, six observational studies and three controlled trials did not explicitly reference the definition of endonyx onychomycosis, thereby lacking a traceable criterion for diagnosis in these cases. This group represented 47.3% of the reviewed studies. Additionally, one controlled trial (5.2%) defined it as a synonym of SWO [36], further indicating inconsistencies in terminology and diagnostic criteria across the literature (Table 3).

4. Discussion

The clinical, histopathological, and mycological features of endonyx onychomycosis were initially described by Tosti et al. [5] and later incorporated into Baran et al.’s new classification [6].
Following a systematic evaluation of the definitions employed in the analyzed papers, of the one hundred and seventy-five cases reported in 28 articles, along with the four cases originally described, seventy-seven cases were identified that referenced or detailed features consistent with the original description. Of these, four articles were based on Baran’s et al. [6] new classification, four cited other sources with a similar concepts [39,40], one study described a compatible definition, and eight described a clinical case compatible with the original report. In all 81 patients, clinical-mycological diagnosis was performed. In contrast, only 13 cases (16.04%) were assessed through a complementary histopathological analysis, in most cases using nail clipping.
To examine the traits outlined in the clinical cases, we chose to categorize them based on the etiological agent. T. soudanense and T violaceum were the first causative agents described; rarer pathogens are T. rubrum and T. tonsurans. For T. soudanense, there were three clinical reports; one is the original report by Tosti et al. [5]. When comparing the other three cases [15,20] to the previously mentioned description (Table 1), the milky white discoloration is present but characterized by patches rather than diffuse white discoloration. In the case of the two Somali siblings, the nail plate surface was altered by lamellar peeling, transverse indentations, coarse pitting, and, in the girl’s case, presented scaling over the hyponychium.
It is important to note that two articles were found during citation searching, which correspond to clinical descriptions prior to the introduction of the endonyx concept, as described by Tosti et al. [5]. These papers report cases with similar characteristics but caused by T. violaceum (Felix Sagher, 1948 [7], and James Hebert Graham, 1972 [14]). However, only the first one could be retrieved. Although it describes only one case of onychomycosis due to T. violaceum, it provides a key element for the histopathological definition of endonyx onychomycosis. Sagher observed that the hyphae were not causing any inflammatory reaction in the surrounding nail plate and noted that there were no fungi present in the subungual area, although the patient had a wavy and thick nail [7].
Mulvaney et al. reported features consistent with endonyx invasion but caused by T. rubrum, an agent not previously reported [16]. It was a case without hyperkeratosis, onycholysis, and with normal nail thickness. The nail surface was mostly normal except for distal lamellar splitting. Histopathology of a nail clipping revealed abundant hyphae invading the nail, except for the subungual keratin, and there was no inflammatory response. This point is crucial according to Tosti et al. [5] and Sagher [7]. T. rubrum could be another potential causative agent of endonyx onychomycosis, as has been seen in the cases reported by Souza et al. [21] and Maki et al. [17]. More histopathological evidence could provide stronger support for these fungi as etiological agents.
In the case of the patient diagnosed with fingernail endonyx onychomycosis caused by T. tonsurans [18], the authors did not report the necessary histopathological evidence to demonstrate the absence of fungal elements in the nail bed, nor any inflammatory changes around the fungi, although clinical characteristics were compatible with the original concept, and it is important to recall that the patient presented a concomitant tinea corporis, thereby suggesting a possible invasion mechanism.
Additionally, a case of Fusarium spp. was described by Negroni et al. [19]; the fungus was isolated independently in two samples that were taken 45 days apart—a result necessary for non-dermatophytic mold onychomycosis diagnosis [41,42,43,44]. However, they referred to onycholysis and a nail thickness greater than 3 mm. Furthermore, the histopathological analysis reported hyphae in the nail plate but did not mention whether there was an absence of inflammatory reaction around the fungus or in the nail bed.
This information highlights the need for further studies to determine whether other fungi could be potential etiological agents of this type of onychomycosis.
Overall, we identified 14 cases that exhibited all the characteristics of the endonyx onychomycosis definition. Interestingly, there seems to be a relationship between the patients’ age, the location of the affected nail, and the presence of other dermatophytic infections. In prepubescent patients, infection of the scalp or colonization by T. soudanense seems to be the route through which fingernails become infected, explaining why fingernail infections are more common in this group. In contrast, in adults, the infection tends to be more frequent on toenails and associated with tinea pedis, where T. rubrum is more common. This is consistent with the infection patterns and age distribution observed in other clinical types of onychomycoses [20,45]. Additionally, three different aspects of the milky white discoloration have been described: patches, longitudinal bands, and diffuse.
The infection mechanism of endonyx onychomycosis reaches the nail plate through the pulp of the fingers and invades the superficial and deep parts, thus causing a laminar separation of the nail without causing onycholysis. However, endonyx onychomycosis is characterized by damage to the inner surface of the nail plate, presenting a diffuse milky white discoloration in the infected nail that occurs due to the presence of tunnels filled with fungal elements in the thickness of the nail plate [5].
The analysis of the observational studies and control trials revealed that 52.5% of the studies exhibited a high risk of measurement bias, mainly due to unclear cited references, but also to the absence of detailed information regarding the clinical features of the reported cases. This limitation prevents an accurate evaluation of the variant-specific manifestations of endonyx onychomycosis. Furthermore, even among studies that cited or described a concept in alignment with the original definition, only one provided sufficient detail regarding the case descriptions. This lack of specificity has resulted in a significant gap in the literature, leading to missing or incomplete data spanning over two and a half decades of research. Moreover, most studies analyzed their data at the global level, describing little information to provide specific insights into the endonyx variant. Given these limitations, further research specifically focused on endonyx onychomycosis is necessary to enhance diagnostic precision and reduce the risk of bias in future studies.
The decision not to contact the authors of studies with limited case information due to time and resource constraints represented a limitation to the review processes used. This was because 67.8% of the data was missing and affected the comprehensiveness of the review process. Although, even if the authors had been contacted, it is unlikely that all missing information would have been available.

5. Conclusions

Onychomycosis endonyx is a rare variant that has a higher prevalence in the continents of Asia (40.5%) and Africa (34.2%), particularly in countries such as India (32%) and Botswana (26.8%). Nevertheless, a significant gap in knowledge was identified during the analysis, especially in etiology, treatment, and prognosis. The clinical and etiological diversity of the cases studied during this review highlights the complexity of their diagnosis and classification, with Trichophyton soudanense and T. violaceum being the most common etiological agents, although other fungi such as Fusarium spp., T. rubrum, and T. tonsurans have also been implicated in rare cases. Additional studies are required to clarify the clinical significance of each of these etiological agents.
The analysis of the clinical features typically presents with a milky white discoloration, without hyperkeratosis or onycholysis; however, there are discrepancies in the reported cases, such as the description of nail surface involvement, and their diagnostic methods, such as the lack of consistent histopathological evidence due to its performance not being mentioned in the studies, or due to differences in the clinical characteristics described, which suggest the need for further research to better understand the full range of manifestations and the responsible fungal agents.
With all the variability for endonyx onychomycosis found in the literature, analyses to draw conclusions on the prognosis or treatment possibilities are difficult. Therefore, emphasis on clinical description and histopathological analysis is essential for confirming the role of less commonly reported fungi. More accurate diagnostics following the points mentioned by Tosti et al. regarding clinical findings, sample collection, and pathological studies for this condition are mandatory.
Meanwhile, the most relevant lesson lies in the fact that the classical presentation of onychomycosis has nail thickness and surface alterations, but in exceptional cases, such as in endonyx onychomycosis, the nails do not present surface or thickness alterations and display only patches, longitudinal bands, or diffuse milky white discoloration. This rare clinical presentation differs significantly from the more common findings that typically guide the diagnosis of onychomycosis. Therefore, it is essential to consider this possibility in the approach to nail pathologies.

Author Contributions

Conceptualization, E.D.-L.-R.-G., R.A., E.M.-H. and R.P.-A.; methodology, E.D.-L.-R.-G., E.M.-H. and R.P.-A.; validation, R.A., E.M.-H. and R.P.-A.; formal analysis, A.V.-G., G.M.-C. and P.B.Z.-S.; investigation, E.D.-L.-R.-G., E.M.-H., R.P.-A. and F.B.-G.; resources, E.D.-L.-R.-G., E.M.-H., R.P.-A. and P.B.Z.-S.; data curation, M.Y.H.-C. and F.B.-G.; writing—original draft preparation, E.D.-L.-R.-G., M.Y.H.-C. and A.V.-G.; writing—review and editing, E.D.-L.-R.-G., R.A., E.M.-H. and R.P.-A.; visualization, P.B.Z.-S. and F.B.-G.; supervision, R.A., E.M.-H. and R.P.-A.; project administration, E.M.-H. and R.P.-A.; funding acquisition, E.D.-L.-R.-G., R.A., E.M.-H. and R.P.-A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received funding from the Secretaría de Investigación y Posgrado (SIP) del Instituto Politécnico Nacional (IPN) under its Research Project 2024 call (Assigned registration No. 20240377).

Acknowledgments

Secretaria de Ciencia, Humanidades, Tecnologías e Innovación (SENCIHTI), and the Programa de Estímulos al Desempeño de los investigadores of Instituto Politécnico Nacional-México (EDI-IPN) for their support in the realization of this article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Wolff, K.; Johnson, R.; Saavedra, A. Disorders of the Nail Apparatus. In Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology, 7th ed.; McGraw-Hill Education: New York, NY, USA, 2014. [Google Scholar]
  2. Nenoff, P.; Reinel, D.; Mayser, P.; Abeck, D.; Bezold, G.; Bosshard, P.P.; Brasch, J.; Daeschlein, G.; Effendy, I.; Ginter-Hanselmayer, G.; et al. S1 Guideline onychomycosis. J. Dtsch. Dermatol. Ges. 2023, 21, 678–692. [Google Scholar] [CrossRef] [PubMed]
  3. Gupta, A.K.; Stec, N.; Summerbell, R.C.; Shear, N.H.; Piguet, V.; Tosti, A.; Piraccini, B.M. Onychomycosis: A review. J. Eur. Acad. Dermatol. Venereol. 2020, 34, 1972–1990. [Google Scholar] [CrossRef]
  4. Hay, R.J.; Baran, R. Onychomycosis: A proposed revision of the clinical classification. J. Am. Acad. Dermatol. 2011, 65, 1219–1227. [Google Scholar] [CrossRef] [PubMed]
  5. Tosti, A.; Baran, R.; Piraccini, B.M. “Endonyx” onychomycosis: A new modality of nail invasion by dermatophytes. Acta Derm. Venereol. 1999, 79, 52–53. [Google Scholar] [CrossRef]
  6. Baran, R.; Hay, R.J.; Tosti, A.; Haneke, E. A new classification of onychomycosis. Br. J. Dermatol. 1998, 139, 567–571. [Google Scholar] [CrossRef] [PubMed]
  7. Sagher, F. Histologic examinations of fungous infections of the nails. J. Investig. Dermatol. 1948, 11, 337–354. [Google Scholar] [CrossRef]
  8. Page, M.J.; Moher, D.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. BMJ 2021, 372, n160. [Google Scholar] [CrossRef]
  9. Jakhar, D.; Grover, C.; Kaur, I. Dendritic pattern: Unique onychoscopic feature in endonyx. J. Am. Acad. Dermatol. 2019, 81, e89–e90. [Google Scholar] [CrossRef]
  10. Chetana, K.; Menon, R.; David, B.G. Onychoscopic evaluation of onychomycosis in a tertiary care teaching hospital: A cross-sectional study from South India. Int. J. Dermatol. 2018, 57, 837–842. [Google Scholar] [CrossRef]
  11. Agrawal, S.; Singal, A.; Grover, C.; Das, S.; Arora, V.K.; Madhu, S.V. Prevalence of onychomycosis in patients with diabetes mellitus: A cross-sectional study from a tertiary care hospital in North India. Indian J. Dermatol. Venereol. Leprol. 2023, 89, 710–717. [Google Scholar] [CrossRef]
  12. Chetana, K.; Menon, R.; David, B.G.; Ramya, M.R. Clinicomycological and histopathological profile of onychomycosis: A cross-sectional study from South India. Indian J. Dermatol. 2019, 64, 272–276. [Google Scholar] [CrossRef] [PubMed]
  13. Agrawal, S.; Singal, A.; Grover, C.; Das, S.; Madhu, S. Clinico-mycological study of onychomycosis in Indian diabetic patients. Indian Dermatol. Online J. 2023, 14, 807–813. [Google Scholar] [CrossRef]
  14. Graham, J.H. Superficial fungus infections. In Dermal Phatology; Harper & Row: Hagerstown, ML, USA, 1972; pp. 137–253. [Google Scholar]
  15. Islahi, S.; Das, A.; Chandra, A.; Sen, M.; Garg, J.; Maurya, K.; Agarwal, J. Endonyx onychomycosis due to Trichophyton soudanense: Rare case with successful treatment. Indian J. Microbiol. 2021, 8, 93–95. [Google Scholar] [CrossRef]
  16. Mulvaney, P.M.; Jellinek, N. Trichophytum rubrum endonyx onychomycosis resistant to standard oral and topical therapies. Dermatol. Online J. 2015, 21. [Google Scholar] [CrossRef]
  17. Maki, N.; Maeda, T.; Harada, K. White onychomycosis with Trichophyton rubrum in a congenital heart disease patient: Endonyx onychomycosis. J. Dermatol. 2020, 47, e229–e230. [Google Scholar] [CrossRef] [PubMed]
  18. Pattanaprichakul, P.; Bunyaratavej, S.; Bunyaratavej, S.; Muanprasart, C.; Matthapan, L.; Varothai, S.; Tangjaturonrusamee, C. Endonyx onychomycosis caused by Trichophyton tonsurans. Indian J. Dermatol. Venereol. Leprol. 2015, 81, 390–392. [Google Scholar] [CrossRef]
  19. Negroni, R.; Arechavala, A.; Bonvehí, P. Problemas clínicos en Micología Médica: Problema no 35. Rev. Iberoam. Micol. 2008, 25. [Google Scholar]
  20. Fletcher, C.; Moore, M.; Hay, R. Endonyx onychomycosis due to Trichophyton soudanense in two Somalian siblings. Br. Assoc. Dermatol. 2001, 145, 687–688. [Google Scholar] [CrossRef] [PubMed]
  21. Souza, L.W.F.; Souza, S.V.T.; Botelho, A.C.d.C. Onicomicose endonix podal por Trichophyton rubrum: Tratamento por terapia fotodinâmica com corante azul de metileno. An. Bras Dermatol. 2013, 88, 1019–1021. [Google Scholar] [CrossRef]
  22. Thakur, R.; Singh Kalsi, A. Clinico-mycological study of onychomycosis in Botswana. J. Dermatol. Cosmetol. 2018, 2, 95–100. [Google Scholar] [CrossRef]
  23. Thakur, R. Spectrum of dermatophyte infections in Botswana. Clin. Cosmet. Investig. Dermatol. 2015, 8, 127–133. [Google Scholar] [CrossRef] [PubMed]
  24. Eba, M.; Njunda, A.L.; Mouliom, R.N.; Kwenti, E.T.; Fuh, A.N.; Nchanji, G.T.; Atashili, J. Onychomycosis in diabetic patients in Fako Division of Cameroon: Prevalence, causative agents, associated factors and antifungal sensitivity patterns. BMC Res. Notes 2016, 9, 494. [Google Scholar] [CrossRef] [PubMed]
  25. Saber, M.; Rafei, M.; Hasanin, A.Z.A.A. Fractional Carbon Dioxide Laser with or Without Topical Terbinafine 1% Cream in the Treatment of Onychomycosis. J. Pharm. Negat. Results 2022, 13, 8220–8241. [Google Scholar] [CrossRef]
  26. Thakur, R. Clinico-mycological updates on Onychomycosis. Int. J. Curr. Microbiol. App. Sci. 2015, 4, 43–47. [Google Scholar]
  27. Sarkar, M.; Ray, R.; Halder, P.; Ghosh, A.P.; Chatterjee, M. Clinico-Mycological Profile of Onychomycosis—A Study in A Tertiary Care Hospital in Kolkata. IOSR J. Dent. Med. Sci. 2016, 15, 78–83. [Google Scholar] [CrossRef]
  28. Iqbal, A.F.; Mahesh, T.U.; Mukesh, B.S.; Rachita, D.; Meghna, P. A clinico-mycological study of onychomycosis at a tertiary care center. Asian J. Med. Sci. 2017, 8, 48–57. [Google Scholar] [CrossRef]
  29. Banik, A.; Durairaj, E.; Lyngdoh, W.V.; Khyriem, A.B.; Sabhapandit, D. Clinico-aetiologic profile of Onychomycoses in a tertiary care centre in northeast India. Trop. Doct. 2018, 48, 136–142. [Google Scholar] [CrossRef]
  30. Dhawan, S.; Sharma, K. Role of Q-switched neodymium-doped yttrium aluminum garnet laser in combination with fractional carbon dioxide laser for the treatment of onychomycosis. Cosmoderma 2024, 4, 95. [Google Scholar] [CrossRef]
  31. Haghani, I.; Shams-Ghahfarokhi, M.; Dalimi Asl, A.; Shokohi, T.; Hedayati, M.T. Molecular identification and antifungal susceptibility of clinical fungal isolates from onychomycosis (uncommon and emerging species). Mycoses 2019, 62, 128–143. [Google Scholar] [CrossRef]
  32. Chi, C.C.; Wang, S.H.; Chou, M.C. The causative pathogens of onychomycosis in southern Taiwan. Mycoses 2005, 48, 413–420. [Google Scholar] [CrossRef]
  33. Friedlander, S.F.; Chan, Y.C.; Chan, Y.H.; Eichenfield, L.F. Onychomycosis does not always require systemic treatment for cure: A trial using topical therapy. Pediatr. Dermatol. 2013, 30, 316–322. [Google Scholar] [CrossRef]
  34. Kozarev, J. Novel Laser Therapy in Treatment of Onychomycosis. J. Laser Health Acad. 2010, 2010, 1–8. [Google Scholar]
  35. Olsen, J.; Lindsø Andersen, P.; Themstrup, L.; Jemec, G.B.E.; Saunte, D.M.L. Optical coherence tomography of onychomycosis: Proposed terminology and a suggestion of practical usage. Arch. Dermatol. Res. 2020, 312, 51–58. [Google Scholar] [CrossRef] [PubMed]
  36. Kolodchenko, Y.; Kolodchenko, Y.V.; Baetul, V.I. A Novel Method for the Treatment of Fungal Nail Disease with 1064 nm Nd: YAG. J. Laser Health Acad. 2013, 2013, 42–47. [Google Scholar]
  37. Zalacain, A.; Merlos, A.; Planell, E.; Cantadori, E.G.; Vinuesa, T.; Viñas, M. Clinical laser treatment of toenail onychomycoses. Lasers Med. Sci. 2018, 33, 927–933. [Google Scholar] [CrossRef] [PubMed]
  38. Viguié, C.; Loria-Kanza, Y.; Verpilleux, M.P. P01.57 Description of 1486 onychomycosis collected in a French observational survey on mycoses in dermatological practice Tinea multis. In Proceedings of the Abstracts of the 14th Congress of the European Academy of Dermatology and Venereology, London, UK, 12–15 October 2005; p. 15. [Google Scholar]
  39. Piraccini, B.M.; Alessandrini, A. Onychomycosis: A review. J. Fungi 2015, 1, 30–43. [Google Scholar] [CrossRef] [PubMed]
  40. Chander, J. Dermatophytosis. In Textbook of Medical Mycology, 2nd ed.; Mehta Publishers: New Delhi, India, 2002; pp. 100–101. [Google Scholar]
  41. Summerbell, R.C.; Cooper, E.; Bun, U.; Jamieson, F.; Gupta, A.K. Onychomycosis: A critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes. Med. Mycol. 2005, 43, 39–59. [Google Scholar] [CrossRef]
  42. Gupta, A.K.; Cooper, E.A.; MacDonald, P.; Summerbell, R.C. Utility of inoculum counting (Walshe and English Criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi. J. Clin. Microbiol. 2001, 39, 2115–2121. [Google Scholar] [CrossRef]
  43. Bombace, F.; Iovene, M.R.; Galdiero, M.; Martora, F.; Nicoletti, G.F.; D’Andrea, M.; Della Pepa, M.E.; Vitiello, M. Non-dermatophytic onychomycosis diagnostic criteria: An unresolved question. Mycoses 2016, 59, 558–565. [Google Scholar] [CrossRef]
  44. Gupta, A.K.; Summerbell, R.C.; Venkataraman, M.; Quinlan, E.M. Nondermatophyte mould onychomycosis. J. Eur. Acad. Dermatol. Venereol. 2021, 35, 1628–1641. [Google Scholar] [CrossRef]
  45. Grover, C.; Khurana, A. Onychomycosis: Newer insights in pathogenesis and diagnosis. Indian J. Dermatol. Venereol. Leprol. 2012, 78, 263–270. [Google Scholar] [CrossRef] [PubMed]
Figure 1. PRISMA 2020 flow diagram.
Figure 1. PRISMA 2020 flow diagram.
Diseases 13 00110 g001
Figure 2. Global distribution of patients diagnosed with endonyx onychomycosis. Note: The 15 cases reported in France, together with its overseas departments and territories (French Caribbean, French Guyana, and Reunion Island), could not be traced to a single location, so they are not shown on the map.
Figure 2. Global distribution of patients diagnosed with endonyx onychomycosis. Note: The 15 cases reported in France, together with its overseas departments and territories (French Caribbean, French Guyana, and Reunion Island), could not be traced to a single location, so they are not shown on the map.
Diseases 13 00110 g002
Table 1. Clinical reports compared to Tosti et al. [5] description. Comparison between the originally described characteristics and the recent characteristics described in clinical reports and a clinical trial with diagnosed endonyx onychomycosis.
Table 1. Clinical reports compared to Tosti et al. [5] description. Comparison between the originally described characteristics and the recent characteristics described in clinical reports and a clinical trial with diagnosed endonyx onychomycosis.
EpidemiologySexMFFMMMMFMFMFMMF
Age (in years)65–691940455125619143653928
Nail localizationTTTNATTFnFnTFnFnTTTT
No. of affected nails1211143NA
Evolution (years)NA90.918NA0.4231
Clinical findingsOriginally describedAbsence of nail bed hyperkeratosisXXX X XX XXXXXX
Absence of onycholysisXXX XXXX XX
Normal nail thicknessXXX XXX XX
Normal nail plate surfaceXXX X XX
Diffuse milky-white discolorationXXXX X
Recently describedTransvers milky white band X X
Milky-white patches X XX
Transvers indentations of nail plates X X XXXXXX
Lamellar peeling X XX
Coarse pitting XX
Scaling over the hyponychium X
distal split XXXX
Nail hyperkeratosis X X
Minimum subungual hyperkeratosis X XXXX
Onycholysis X
Cubbing X
Affection of the lunula X X NA
Sample collectionOriginally described1XXX X
2XXXXX XXXXXXXXX
Pathological study3XXXXNAXNAXNA
4XXXX
5XXX X
6XXXXX
7XXX
8XXX X
9XXX
Etiological AgentT. soudanense X XX
T. violaceum X
Recently describedT. rubrum XX XXXX
T. Tonsurans X
Fusarium spp. X
Associated tineasTinea capitis X XX
T. soudanense XX
Dermatophytid reaction X
Tinea pedisXXX
T. soudanenseXXX
Tinea corporis X
T. tonsurans X
Reference[5][7][15][16][17][18][19][20][21] !
F—Female. M—Male. T—Toenail. Fn—Fingernail. NA—Not available. Characteristics originally described: 1. The nail plate was so firmly attached to the nail bed that clipping to obtain subungual debris produced pain and diffuse bleeding. 2. Direct microscopy with filaments. 3. Abundance of fungal elements in the nail plate. 4. Absence of fungal elements in the nail bed. 5. No hyperkeratosis. 6. Nail bed showed no inflammatory changes. 7. Normal hyponychium, without hyphae. 8. Normal hyponychium, without hyphae. 9. Fungi almost exclusively confined to the ventral nail plate. ! Clinical trial.
Table 2. Global distribution of reported cases with a diagnosis of endonyx onychomycosis.
Table 2. Global distribution of reported cases with a diagnosis of endonyx onychomycosis.
ContinentCountry/RegionRegionNo. of Cases per ArticleNo. of Cases per CountryNo. of Cases per ContinentReferences
AfricaBotswanaGaborone454760[22]
2[23]
CameroonBuea and Limbe (Fako)99[24]
Somalia-22[20]
EgyptPortsaid22[25]
AsiaIndiaMuzaffarnagar305671[26]
Kolkata15[27]
Delhi5[14]
Mumbai2[28]
Puducherry2[12]
Shillong1[29]
Chandigarh1[30]
IranSari99[31]
TaiwanChiayi33[32]
ThailandBangkok11[18]
The Philippines-11[15]
Japan-11[17]
AmericaUnited States of AmericaCalifornia81015[33]
New York1[7]
Rhode Island1[16]
BrazilMontes Claros44[21]
ArgentinaBuenos Aires11[19]
EuropeSerbiaSremska Mitrovica6614[34]
France/ItalyCannes/Bologna33[5]
DenmarkRoskilde22[35]
UkraineKiev22[36]
SpainBarcelona11[37]
America, Africa, EuropeFrance and Overseas Departments and TerritoriesFrance, French Caribbean, French Guiana, Réunion151515[38]
Table 3. Assessment of the risk of bias through the analysis of the references cited to define “Endonyx onychomycosis” and the diagnostic approach performed.
Table 3. Assessment of the risk of bias through the analysis of the references cited to define “Endonyx onychomycosis” and the diagnostic approach performed.
No.Study DesignReference CitedDiagnostic Approach PerformedReference
A New Classification of Onychomycosis [6]OtherWritten ConceptUnclearSynonym of White Superficial OnychomycosisClinical FeaturesDirect MicroscopyHistopathologyCulture
1Observational studyX XX X[28]
2Clinical Trial XX X[36]
3Clinical Trial X XX X[37]
4Observational study X, [40] XX X[27]
5Observational studyX XX X[29]
6Observational study X XX X[22]
7Observational study X, [39] XXX 1X[13]
8Observational studyX XX X[26]
9Observational study X XXX *X[12]
10Observational study X XX * [38]
11Clinical trial X XX X[25]
12Observational study X XX X[31]
13Clinical trial X XX X[34]
14Clinical trial X X X[33]
15Observational study X XX X[24]
16Observational study X, [39] XX X[22]
17Observational study X, [39] X X[30]
18Observational study X XX X[23]
19Observational studyX X X 2X[32]
Nail sample was taken through: 1 Nail punch or nail clipping; 2 Nail clipping. Note: * Not performed in all patients, so it is unclear whether endonyx onychomycosis-diagnosed patients were evaluated with this technique.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

De-La-Rosa-Garibay, E.; Arenas, R.; Herrera-Castro, M.Y.; Valdez-Gaona, A.; Moreno-Coutiño, G.; Zarate-Segura, P.B.; Bastida-González, F.; Martínez-Herrera, E.; Pinto-Almazán, R. Onychomycosis Endonyx: A Systematic Review. Diseases 2025, 13, 110. https://doi.org/10.3390/diseases13040110

AMA Style

De-La-Rosa-Garibay E, Arenas R, Herrera-Castro MY, Valdez-Gaona A, Moreno-Coutiño G, Zarate-Segura PB, Bastida-González F, Martínez-Herrera E, Pinto-Almazán R. Onychomycosis Endonyx: A Systematic Review. Diseases. 2025; 13(4):110. https://doi.org/10.3390/diseases13040110

Chicago/Turabian Style

De-La-Rosa-Garibay, Ernesto, Roberto Arenas, Martha Y. Herrera-Castro, Alicia Valdez-Gaona, Gabriela Moreno-Coutiño, Paola Berenice Zarate-Segura, Fernando Bastida-González, Erick Martínez-Herrera, and Rodolfo Pinto-Almazán. 2025. "Onychomycosis Endonyx: A Systematic Review" Diseases 13, no. 4: 110. https://doi.org/10.3390/diseases13040110

APA Style

De-La-Rosa-Garibay, E., Arenas, R., Herrera-Castro, M. Y., Valdez-Gaona, A., Moreno-Coutiño, G., Zarate-Segura, P. B., Bastida-González, F., Martínez-Herrera, E., & Pinto-Almazán, R. (2025). Onychomycosis Endonyx: A Systematic Review. Diseases, 13(4), 110. https://doi.org/10.3390/diseases13040110

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop